SEARCH

SEARCH BY CITATION

References

  • Aldinucci, D., Lorenzon, D., Cattaruzza, L., Pinto, A., Gloghini, A., Carbone, A. & Colombatti, A. (2008) Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. International Journal of Cancer, 122, 769776.
  • Aldinucci, D., Rapana’, B., Olivo, K., Lorenzon, D., Gloghini, A., Colombatti, A. & Carbone, A. (2010a) IRF4 is modulated by CD40L and by apoptotic and anti-proliferative signals in Hodgkin lymphoma. British Journal of Haematology, 148, 115118.
  • Aldinucci, D., Gloghini, A., Pinto, A., De, F.R. & Carbone, A. (2010b) The classical Hodgkin’s lymphoma microenvironment and its role in promoting tumour growth and immune escape. Journal of Pathology, 221, 248263.
  • van den Berg, A., Visser, L. & Poppema, S. (1999) High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin’s lymphoma. The American Journal of Pathology, 154, 16851691.
  • Biggar, R.J., Johansen, J.S., Smedby, K.E., Rostgaard, K., Chang, E.T., Adami, H.O., Glimelius, B., Molin, D., Hamilton-Dutoit, S., Melbye, M. & Hjalgrim, H. (2008) Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma. Clinical Cancer Research, 14, 69746978.
  • Carbone, A., Gloghini, A., Gattei, V., Aldinucci, D., Degan, M., De, P.P., Zagonel, V. & Pinto, A. (1995) Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin’s disease cell lines. Blood, 85, 780789.
  • Carbone, A., Gloghini, A., Aldinucci, D., Gattei, V., Dalla-Favera, R. & Gaidano, G. (2002) Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin’s disease. British Journal of Haematology, 117, 366372.
  • Cattaruzza, L., Gloghini, A., Olivo, K., Di, F.R., Lorenzon, D., De, F.R., Carbone, A., Colombatti, A., Pinto, A. & Aldinucci, D. (2009) Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin’s lymphoma. International Journal of Cancer, 125, 10921101.
  • Cattaruzza, L., Fregona, D., Mongiat, M., Ronconi, L., Fassina, A., Colombatti, A. & Aldinucci, D. (2011) Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts. International Journal of Cancer, 128, 206215.
  • Drexler, H.G. (1993) Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines. Leukemia and Lymphoma, 9, 125.
  • Falini, B., Fizzotti, M., Pucciarini, A., Bigerna, B., Marafioti, T., Gambacorta, M., Pacini, R., Alunni, C., Natali-Tanci, L., Ugolini, B., Sebastiani, C., Cattoretti, G., Pileri, S., Dalla-Favera, R. & Stein, H. (2000) A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood, 95, 20842092.
  • Fischer, M., Juremalm, M., Olsson, N., Backlin, C., Sundstrom, C., Nilsson, K., Enblad, G. & Nilsson, G. (2003) Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue. International Journal of Cancer, 107, 197201.
  • Gualco, G., Weiss, L.M. & Bacchi, C.E. (2010) MUM1/IRF4: a review. Applied Immunohistochemistry and Molecular Morphology, 18, 301310.
  • Herbst, H., Foss, H.D., Samol, J., Araujo, I., Klotzbach, H., Krause, H., Agathanggelou, A., Niedobitek, G. & Stein, H. (1996) Frequent expression of interleukin-10 by Epstein–Barr virus-harboring tumor cells of Hodgkin’s disease. Blood, 87, 29182929.
  • Klein, U., Casola, S., Cattoretti, G., Shen, Q., Lia, M., Mo, T., Ludwig, T., Rajewsky, K. & Dalla-Favera, R. (2006) Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nature Immunology, 7, 773782.
  • Kuppers, R. (2009) The biology of Hodgkin’s lymphoma. Nature Reviews. Cancer, 9, 1527.
  • Lampariello, F. (2000) On the use of the Kolmogorov–Smirnov statistical test for immunofluorescence histogram comparison. Cytometry, 39, 179188.
  • Lamprecht, B., Kreher, S., Anagnostopoulos, I., Johrens, K., Monteleone, G., Jundt, F., Stein, H., Janz, M., Dorken, B. & Mathas, S. (2008) Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3alpha. Blood, 112, 33393347.
  • Lin, L., Nonoyama, S., Oshiba, A., Kabasawa, Y. & Mizutani, S. (2003) TARC and MDC are produced by CD40 activated human B cells and are elevated in the sera of infantile atopic dermatitis patients. Journal of Medical and Dental Sciences, 50, 2733.
  • Pinto, A., Aldinucci, D., Gattei, V., Zagonel, V., Tortora, G., Budillon, A. & Cho-Chung, Y.S. (1992) Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3’,5’-cyclic monophosphate. Proceedings of the National Academy of Sciences of the United States of America, 89, 88848888.
  • Re, D., Hofmann, A., Wolf, J., Diehl, V. & Staratschek-Jox, A. (2000) Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95. Experimental Hematology, 28, 3135.
  • Saito, M., Gao, J., Basso, K., Kitagawa, Y., Smith, P.M., Bhagat, G., Pernis, A., Pasqualucci, L. & Dalla-Favera, R. (2007) A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell, 12, 280292.
  • Shaffer, A.L., Emre, N.C., Lamy, L., Ngo, V.N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., Zhao, H., Zeng, Y., Chen, B., Epstein, J. & Staudt, L.M. (2008) IRF4 addiction in multiple myeloma. Nature, 454, 226231.
  • Shaffer, A.L., Emre, N.C., Romesser, P.B. & Staudt, L.M. (2009) IRF4: immunity. Malignancy! Therapy? Clinical Cancer Research, 15, 29542961.
  • Skinnider, B.F. & Mak, T.W. (2002) The role of cytokines in classical Hodgkin lymphoma. Blood, 99, 42834297.
  • Skinnider, B.F., Kapp, U. & Mak, T.W. (2002) The role of interleukin 13 in classical Hodgkin lymphoma. Leukemia and Lymphoma, 43, 12031210.
  • Steidl, C., Lee, T., Shah, S.P., Farinha, P., Han, G., Nayar, T., Delaney, A., Jones, S.J., Iqbal, J., Weisenburger, D.D., Bast, M.A., Rosenwald, A., Muller-Hermelink, H.K., Rimsza, L.M., Campo, E., Delabie, J., Braziel, R.M., Cook, J.R., Tubbs, R.R., Jaffe, E.S., Lenz, G., Connors, J.M., Staudt, L.M., Chan, W.C. & Gascoyne, R.D. (2010) Tumor-associated macrophages and survival in classic Hodgkin’s lymphoma. The New England Journal of Medicine, 362, 875885.
  • Tamura, T., Tailor, P., Yamaoka, K., Kong, H.J., Tsujimura, H., O’Shea, J.J., Singh, H. & Ozato, K. (2005) IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. Journal of Immunology, 174, 25732581.
  • Wolf, J., Kapp, U., Bohlen, H., Kornacker, M., Schoch, C., Stahl, B., Mucke, S., von, K.C., Fonatsch, C., Schaefer, H.E., Hansmann, M.L. & Diehl, V. (1996) Peripheral blood mononuclear cells of a patient with advanced Hodgkin’s lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. Blood, 87, 34183428.
  • Xu, D., Zhao, L., Del, V.L., Miklossy, J. & Zhang, L. (2008) Interferon regulatory factor 4 is involved in Epstein–Barr virus-mediated transformation of human B lymphocytes. Journal of Virology, 82, 62516258.